Cambridge, MA · Founded 2021 · Privately Held (backing)
Developer of a biotechnology company intended to enhance the quality of life for individuals suffering from cancer. Crossbow Therapeutics is based in Cambridge, MA and was founded in 2021. Its last reported valuation was $125 million in Jul 2023. It has raised $198 million across 2 recorded rounds; the latest was a $30.3 million early-stage round in Sep 2025.
Last reported valuation
$125.0M
Oct 2026
Priced at
—
Total raised
$198.3M
Last round
Early Stage VC
Sep 2025
Cap table — not yet on record
Crossbow Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Crossbow Therapeutics with a free account
·The complete investor list: 13 names
·Watch Crossbow Therapeutics: the Monday email on marks, rounds and moves
Where does Crossbow Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Crossbow Therapeutics's 2 recorded funding rounds.
